Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page
- CheckyesterdayChange DetectedDifference0.6%

- Check8 days agoChange DetectedRevision: v3.5.5 was added to the record history, while Revision: v3.5.4 was removed. This marks a new update to the page’s history data.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision tag v3.5.4 was added to the Record History and the previous v3.5.3 entry was removed, indicating an updated revision state for the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s interface revision/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a site release without changing the study record details shown.SummaryDifference0.1%

- Check58 days agoChange DetectedRelease notes updated to add Revision: v3.5.2 and remove Revision: v3.5.0.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.